Our Commitment

At Cohera Medical, Inc.® we are committed to creating surgical adhesives and sealants that improve patient care and quality of life – for all surgical procedures, applications and specialties.

AdvaMed Code of Ethics

Our commitment to improving patient care is reflected in our support of the AdvaMed Code of Ethics, a set of guidelines calling for transparency in collaborative exchanges between healthcare professionals and medical technology companies like Cohera Medical. As a Code of Ethics Supporter, Cohera Medical is licensed to display the AdvaMed Code of Ethics Logo, signifying our understanding of the guidelines defined in the AdvaMed Code.

Cohera Medical believes in helping clinicians select medical technologies based solely on their effectiveness and value. Learn more about the AdvaMed Code of ethics.

Our Technology

Cohera Medical has entered the European market with its first product offering, TissuGlu® Surgical Adhesive,* which is indicated in the European market for the approximation of tissue layers where subcutaneous deadspace exists between the tissue planes in large flap surgical procedures such as abdominoplasty. Cohera’s researchers designed TissuGlu to help surgeons improve outcomes and eliminate the need for surgical drains in a wide range of surgical procedures. TissuGlu Surgical Adhesive is resorbable, biocompatible for internal use, uses no human or animal based ingredients and forms a strong bond between tissues.

Our Future

Cohera Medical’s scientific leaders continue to explore new clinical applications for the company’s patented technologies, including new surgical adhesives and sealants that target other medical applications. This includes their latest innovation, Sylys® Surgical Sealant† for sealing gastrointestinal anastomoses, and a new product for hernia mesh fixation.

Sylys is designed to help reduce leakage in gastrointestinal procedures by providing additional support to the anastomosis during the first few days of healing, when the development of leaks is most likely to occur.  The sealant is applied as a viscous fluid which cures rapidly to create a flexible, elastomeric seal upon application to the tissue. In-vivo, the product degrades in a few weeks and is resorbed by the body.

†Disclaimer: Hernia mesh fixation and bowel sealant products are not currently available for sale or distribution and have not been approved by the U.S. FDA or any other country’s regulatory authority. The devices described are currently limited to non-human investigational use only.

Get Updates

Join our mailing list to be among the first to receive updates about new product developments and other news from Cohera Medical.

Sign Up Now

Cohera Medical Corporate Headquarters

227 Fayetteville Street
Suite 900
Raleigh, NC 27601, USA
Phone: 1-800-641-7458
Email – cs@coheramed.com

Cohera Medical, Inc.

c/o HealthLink Europe
De Tweeling 20-22
‘s-Hertogenbosch 5215 MC
The Netherlands

Tel: +31-(0)73-3030500
Fax: +31-(0)13-5479301
Email: cs@healthlinkeurope.com